AI assistant
VOLITIONRX LTD — Director's Dealing 2022
Apr 8, 2022
34395_dirs_2022-04-08_28a4b3c5-30e4-4cd2-b5bf-9eb5c0f78574.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-04-07-05:00
Reporting Person: TERRELL JASON BRADLEY MD (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-07-05:00 | Common Stock | A | 12300 | — | Acquired | 37249 | Direct |
| 2022-04-07-05:00 | Common Stock | A | 955 | — | Acquired | 955 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-07-05:00 | Stock Option (Right to Buy) | $3.40 | A | 22668 | Acquired | 2031-08-03-05:00 | Common Stock (22668) | Direct |
| 2022-04-07-05:00 | Stock Option (Right to Buy) | $3.40 | A | 1760 | Acquired | 2031-08-03-05:00 | Common Stock (1760) | Indirect |
Footnotes
F1: On August 3, 2021, the reporting person was awarded 35,145 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,300 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 6,150 units on each of August 3, 2022 and August 3, 2023, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F2: On August 3, 2021, the spouse of the reporting person was awarded 2,730 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 955 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two installments of 477 units and 478 units on each of August 3, 2022 and August 3, 2023, respectively. Upon vesting and settlement, the spouse of the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F3: On August 3, 2021, the reporting person was granted an option to purchase 64,766 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 22,668 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 11,334 shares on each of August 3, 2022 and August 3, 2023, respectively.
F4: On August 3, 2021, the spouse of the reporting person was granted an option to purchase 5,030 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 1,760 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 880 shares on each of August 3, 2022 and August 3, 2023, respectively.